Virtual Journal Club: Diabetic Retinopathy Trends and Disparities in Younger Patients: The Implications for Managed Care

Learn About:

1. Available evidence pertaining to the incidence and burden of DR/DME in younger adults
2. Current disparities in the care of DR/DME
3. The impact of utilization management programs on SDOH outcomes
4. Timely screening and prompt intervention among underserved members with DR/DME

Expert Faculty Presenters:

Jeffrey D. Dunn, PharmD, MBA President and CEO Cooperative Benefits Group (CBG) Click here for biography Rishi Singh, MD Vice President and Chief Medical Officer Cleveland Clinic Martin North and South Hospitals Click here for biography Jacqueline Shaia, BS PhD Student Case Western Reserve University Click here for biography

Target Audience
This activity is designed to meet the educational needs of managed care pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.

Statement of Need/Program Overview
Managed care professionals are tasked with staying up-to-date on multiple disease states to improve care management for a large and diverse patient populations. Therefore, managed care professionals can benefit from timely educational opportunities that focus on the latest clinical updates and payer implications through peer-to-peer discussion to stay informed. In retinal disease management, specifically AMD and DR/DME, payers need increased knowledge and competence to improve access and care for certain patient populations, including younger patients and underserved communities.

Educational Objectives
After completing this activity, the participant should be better able to:

• Review available evidence pertaining to the incidence and burden of DR/DME in younger adults
• Identify current disparities in the care of DR/DME
• Evaluate the impact of utilization management programs on SDOH outcomes
• Recommend timely screening and prompt intervention among underserved members with DR/DME

Accreditation Information

Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Impact Education, LLC. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Medical Education Resources designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Medical Education Resources designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

UAN: JA0003680-9999-24-209-L01-P
Type of Activity: Knowledge-based

Continuing Nursing Education
Medical Education Resources designates this live activity for a maximum of 1.0 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1.0 contact hours.

Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

DISCLAIMER
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Impact Education, LLC, and/or Regeneron Pharmaceuticals, Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

FEE INFORMATION
There is no fee for this educational activity.